Rubicon Genomics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Rubicon Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0122
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) analysis, Aneuploidy, circulating tumor deoxyribose nucleic acid (ctDNA) analysis, and gene expression analysis. It employs high sensitivity ligation-based amplification, and quasi-random primed linear amplification technologies in its sequencing kits. Rubicon Genomics’ sequencing kits find applications in Formalin-fixed, paraffin-embedded (FFPE) DNA sequencing, DNA sequencing, ribose nucleic acid (RNA) sequencing, pre-implantation genetic screening and diagnosis (PGS, PGD), and chromatin immunoprecipitation sequencing (ChIP-seq). Rubicon Genomics is headquartered in Ann Arbor, Michigan, the US.

Rubicon Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Rubicon Genomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Rubicon Genomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Rubicon Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Partnerships 11
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 12
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 15
Acquisition 16
Takara Bio Acquires Rubicon Genomics for USD75 Million 16
Rubicon Genomics Inc – Key Competitors 17
Rubicon Genomics Inc – Key Employees 18
Rubicon Genomics Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Rubicon Genomics Inc, Medical Equipment, Key Facts 2
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Rubicon Genomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Rubicon Genomics Inc, Deals By Market, 2012 to YTD 2018 8
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 12
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 15
Takara Bio Acquires Rubicon Genomics for USD75 Million 16
Rubicon Genomics Inc, Key Competitors 17
Rubicon Genomics Inc, Key Employees 18

List of Figures
Rubicon Genomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Rubicon Genomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Rubicon Genomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Rubicon Genomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Rubicon Genomics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brookshire Grocery Co:企業の戦略・SWOT・財務情報
    Brookshire Grocery Co - Strategy, SWOT and Corporate Finance Report Summary Brookshire Grocery Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Biofortuna Ltd:企業の製品パイプライン分析2018
    Summary Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked and freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogene …
  • Sypris Solutions Inc (SYPR):企業の財務・戦略的SWOT分析
    Sypris Solutions Inc (SYPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Selvita SA (SLV):企業の財務・戦略的SWOT分析
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Saudi Industrial Export Company (4140):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Export Company (SIEC) is a chemical providing company that imports, exports and sales specialty chemicals, fertilizers, industrial materials and commodities. The company's fertilizers include diammonium phosphate, sulphur, urea, triple super phosphate, granular triple super …
  • Weis Markets, Inc.:戦略・SWOT・企業財務分析
    Weis Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Weis Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務分析
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NEXTracker Inc:電力:M&Aディール及び事業提携情報
    Summary NEXTracker Inc (NEXTracker), a subsidiary of Flex Ltd, is a renewable energy company. The company is engaged in the design, development, and manufacture of single-axis solar trackers for the power plants. It offers services such as design and engineering, project management, installation, pe …
  • Seven Bank, Ltd.:企業の戦略・SWOT・財務情報
    Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Toshiba America Electronic Components, Inc.:企業の戦略的SWOT分析
    Toshiba America Electronic Components, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Karo Pharma AB (KARO):製薬・医療:M&Aディール及び事業提携情報
    Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new phar …
  • MyoKardia Inc (MYOK):製薬・医療:M&Aディール及び事業提携情報
    Summary MyoKardia Inc (MyoKardia) is a clinical stage biopharmaceutical company. The company utilizes precision medicine platform to develop therapies for rare cardiovascular diseases including heritable cardiomyopathies. The company's pipeline products include therapeutic programs for the treatment …
  • LSI Industries Inc (LYTS):企業の財務・戦略的SWOT分析
    LSI Industries Inc (LYTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MORRE-TEC Industries, Inc.:企業の戦略・SWOT・財務情報
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Prismic Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a pharmaceutical company that provides research and development of prescription drugs which has unique safety profiles. The company develops drugs for inflammatory diseases and oxidative stress disorders. It pipeline products are used …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Almac Diagnostics Ltd:製品パイプライン分析
    Summary Almac Diagnostics Ltd (Almac Diagnostics), formerly ArraDx Ltd, a subsidiary of Almac Group Ltd, medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company’s products pipeline includes ColDx, DDRD, AADx, prostate Dx, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆